M
y colleagues and I have been 
calling for a fundamental 
shift in how the biologicals industry 
screens for microbes. Microbial 
product performance remains 
inconsistent because the indus­
try has been screening for func­
tion alone, and that will never be 
enough to deliver what farmers 
need from biological products.
A microbe must colonize 
and persist in a soil 
community that 
is already 
there. 
That’s what farmers need, especially as markets and weather grow more 
volatile. The ques-tion is whether a product wins often enough, across 
enough variation, that a farmer can rely on it and a partner can build a 
program on it.
Jord recently launched 9311, our first commercially available bios­
timulant for soy-beans and winner of the 2026 “Biological Crop Input 
Solution of the Year” award. It is built on microbial activator technology, 
which evaluates microbes for their ability to colonize a root, persist 
through a season, activate other beneficial microbes and func-tion 
alongside everything already in the field.
Across three years of soybean field trials, 9311 delivered a 
2.6-bushel-per-acre average yield advantage over elite industry-
standard seed treatments and biologicals, with a 79 percent 
win rate, where a win is greater than 0.5 bushel per acre. Tri­
als also measured a 30 percent increase in early-season 
biomass over an elite commercial treatment base.
Those trials spanned low-, medium- and high-
yield environments across dry, wet and mixed 
conditions. Commercial trials in 2026 are showing 
similar results in emergence and vigor, with prom­
ising increases in nodulation. 
We screened these microbes not only for what 
they do, but also for how they fit into re-al-world soil 
and cropping systems, and how they activate other 
beneficial microbes. We hold our products to the 
standard that microbial activator technology sets, 
drawn from a proprietary collection of more than 
6,500 isolates curated over three decades. That’s 
a higher bar, and it eliminates candidates that look 
excellent in the lab but fail in the field. It’s why 9311’s 
results have held across four years of variable condi­
tions. This was designed, not discovered at random.
9311 is our first public proof that the process 
works, and we’re offering partners a full discovery ap­
proach they can apply to their own pipelines. Farmers 
deserve tools that work acre after acre, season after sea­
son. That has always been our standard. 9311 clears it, and 
it will not be the last. If you’re building a biological program, 
we’re ready to partner.
Farmers deserve tools that work 
acre after acre,season after season.
BIOLOGICALS
Dr. Keri Carstens  President and CEO, Jord BioScience
DECEMBER 2026  SEEDWORLD.COM /  37

View this content as a flipbook by clicking here.